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Background
Alzheimer’s Disease (AD) Research has long been focusing
on Ab-containing amyloid plaque deposition and tau-con-
taining tangles. However, recent clinical trial outcomes by
Ab-lowering approaches have been disappointing. As an
alternative approach, the present study focuses on
mechanisms that prevent neuronal loss, another pathologi-
cal hallmark of AD. Specifically, we have uncovered an
unexpected role of glial cell line-derived neurotrophic
factor (GDNF) in AD.
Methods
The location of the Sun Health Research Institute has
allowed us access to deceased patients’ brain within
2.5 hours. We have previously developed a method to
quickly isolate neurons from postmortem brains, and
grow primary neurons in culture for an extended period
(Konishi et al., Am J Pathol. 2002, 161(5):1567-76). Taking
advantage of this unique resource, we have now used pri-
mary cortical neurons from rapidly autopsied aged human
brains to explore differences between cortical neurons
from AD brain and those from non-demented healthy
elderly (ND).
Results
Using this system, we have made a number of interest-
ing findings. First, compared with ND neurons, there is
a selective reduction in the expression of specific GDNF
family receptor in AD neurons. Second, GDNF and the
GDNF family member enhanced the receptor expression
in ND neurons but not in AD neurons. Consequently,
GDNF supported the survival and promoted the growth
of neuronal processes of ND neurons but not AD neu-
rons. Remarkably, introduction of specific receptor to
AD neurons restored GDNF enhancement of cell survi-
val. Finally, the survival effects of GDNF- receptor path-
way in ND neurons appear to be mediated by the
specific signal transduction pathway.
Conclusion
Taken together, the present study reveals a novel role of
GDNF in cortical neuronal survival in normal aged brains.
Moreover, our results demonstrate that a key difference
between the NC and AD neurons is the presence of speci-
fic GDNF receptor, suggesting that up-regulation of
GDNF receptor is a potential therapeutic strategy for AD.
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